Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.082x

Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a cash flow conversion efficiency ratio of -0.082x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-4.35 Million ≈ $-11.66K USD) by net assets (ILA53.22 Million ≈ $142.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tikun Olam Cannbit Pharmaceuticals Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Tikun Olam Cannbit Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Unlimited Travel Group UTG AB (publ) ST:UTG	1.638x
Minesto AB ST:MINEST	-0.057x
PermRock Royalty Trust NYSE:PRT	-0.010x
Sc Engineering KO:023960	-0.171x
Obducat AB (publ) F:OBD	0.647x
Perusahaan Sadur Timah Malaysia Perstima Bhd KLSE:5436	0.069x
Pico (Thailand) Public Company Limited BK:PICO	-0.070x
Seoam Machinery Industry Co.Ltd KQ:100660	-0.021x

Annual Cash Flow Conversion Efficiency for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Tikun Olam Cannbit Pharmaceuticals Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA-5.35 Million ≈ $-14.34K	ILA-3.77 Million ≈ $-10.11K	0.705x	+870.69%
2023-12-31	ILA33.04 Million ≈ $88.59K	ILA-3.02 Million ≈ $-8.11K	-0.092x	+41.26%
2022-12-31	ILA116.92 Million ≈ $313.46K	ILA-18.22 Million ≈ $-48.84K	-0.156x	+3.30%
2021-12-31	ILA143.82 Million ≈ $385.59K	ILA-23.17 Million ≈ $-62.13K	-0.161x	+10.07%
2020-12-31	ILA136.06 Million ≈ $364.77K	ILA-24.38 Million ≈ $-65.36K	-0.179x	-433.18%
2019-12-31	ILA99.87 Million ≈ $267.75K	ILA-3.36 Million ≈ $-9.00K	-0.034x	+99.79%
2018-12-31	ILA108.00K ≈ $289.54	ILA-1.76 Million ≈ $-4.71K	-16.278x	-7635.02%
2017-12-31	ILA-492.00K ≈ $-1.32K	ILA-106.29K ≈ $-284.95	0.216x	--

About Tikun Olam Cannbit Pharmaceuticals Ltd

TA:TKUN Israel Drug Manufacturers - Specialty & Generic

Market Cap

$304.55 Million

ILA113.60 Billion ILA

Market Cap Rank

#24007 Global

#339 in Israel

Share Price

ILA1337.00

Change (1 day)

-11.75%

52-Week Range

ILA17.03 - ILA2371.00

All Time High

ILA7500.00